A tetrahydronaphthyridine compound and a process for preparing the same

PK140732AUndetermined Publication Date: 2010-05-20TANABE PHARMA CORP
0 Cites 0 Cited by

Patent Information

Application Number
PK200500302
Authority / Receiving Office
PK · PK
Patent Type
Applications
Current Assignee / Owner
Publication Date
2010-05-20
Patent Text Reader

Abstract

A novel compound of the formula (I): wherein R1 is alkoxycarbonyl or the like, R2 is alkyl or the like; R3 is hydrogen or the like; R4 is alkylene or the like; R5 is optionally substituted heterocyclic group; R6, R7, and R8 are independently hydrogen; alkyl, alkoxy, or the like; R10 is optionsally substituted aromatic ring, or the like; which has an inhibitory activity against cholesteryl ester transfer protein (CETP).
Need to check novelty before this filing date? Find Prior Art